Advanced Prostate Cancer Radioligand Therapy in India: First Approved Pluvicto Treatment Explained
Advanced prostate cancer radioligand therapy in India marks a breakthrough with the approval of Pluvicto. Learn about Lutetium-177, PSMA-targeted treatment, significance, exam relevance, FAQs, and MCQs. Introduction to a Landmark Medical Achievement India has achieved a significant milestone in cancer treatment with the launch of its first regulatory authority-approved radioligand therapy for advanced prostate cancer….
